GlassScriptPhysician profile
Mark Jason Douglas
NPI 1679576516
$4,666.05
in general payments reported to CMS, 2019-2025
16 companies · $548 in 2025
The $548 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $136 · 2021: $234 · 2022: $476 · 2023: $1,946 · 2024: $788 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,082 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,081.99 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $1,653.57 | 2019-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $883.45 | 2019-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $603.58 | 2022-2025 | Ozurdex, Durysta |
| Apellis Pharmaceuticals, INC. | $331.38 | 2022-2025 | Syfovre |
| Genentech USA, INC. | $307.97 | 2020-2025 | Vabysmo, Susvimo |
| Allergan, INC. | $261.40 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $173.94 | 2019-2020 | |
| Dutch Ophthalmic, USA | $111.05 | 2024-2025 | Eva, Combined Machine, Tissueblue |
| Sight Sciences, INC. | $100.00 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Coherus Oncology, INC. | $58.33 | 2023 | |
| Astellas Pharma US INC | $35.96 | 2024-2025 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $35.48 | 2022 | |
| Harrow Eye, LLC | $32.65 | 2025 | |
| Kala Pharmaceuticals, INC. | $31.80 | 2019 | |
| Ani Pharmaceuticals, INC. | $30.31 | 2025 | Iluvien |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $15.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.